BioNTech SE (BNTX) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of BioNTech SE and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
BNTX
BioNTech SE
$96.73HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
UTHR
United Therapeutics Corporation
$497.11HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
Total return — BNTX vs UTHR
growth of $100 · dividends reinvested · last 7yBNTX +598.3% (+32.0%/yr)UTHR +543.9% (+30.5%/yr)BNTX compounded faster over this window
BNTX UTHR
BNTX vs UTHR: by the numbers
- •BNTX is the larger company ($24.30B vs $21.10B market cap).
- •UTHR is profitable (41.56% net margin) while BNTX runs a net loss (-62.98%).
- •BNTX grew revenue faster over the past five years (40.61% vs 14.68% CAGR).
Metrics side by side
Valuation
| Metric | BNTX | UTHR |
|---|---|---|
| P/E ratio | N/A | 17.81 |
| Forward P/E | N/A | 19.01 |
| P/S ratio | 7.85 | 6.69 |
| P/B ratio | 1.20 | 3.30 |
| EV / EBITDA | N/A | 12.91 |
| FCF yield | 2.55% | 5.18% |
Profitability
| Metric | BNTX | UTHR |
|---|---|---|
| Gross margin | 70.98% | 86.14% |
| Operating margin | -22.63% | 44.49% |
| Net margin | -62.98% | 41.56% |
| ROE | -9.62% | 20.48% |
| ROIC | -10.37% | 17.69% |
Growth (annualized)
| Metric | BNTX | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | 40.61% | 14.68% |
| EPS CAGR (5Y) | N/A | 20.93% |
| FCF CAGR (5Y) | N/A | 14.31% |
| Total return CAGR (5Y) | -22.49% | 19.17% |
Frequently asked
- Which has grown faster, BNTX or UTHR?
- Over the past five years, BNTX grew revenue faster — BNTX at a 40.61% CAGR versus UTHR at 14.68%.
- Is BNTX or UTHR more profitable?
- UTHR runs the higher net margin — BNTX at -62.98% versus UTHR at 41.56%.
- How have BNTX and UTHR total returns compared?
- Over the past 5 years, BNTX delivered -22.49% and UTHR delivered 19.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
United Therapeutics P/E ratioBioNTech SE ROEUnited Therapeutics ROEBioNTech SE operating marginUnited Therapeutics operating marginBioNTech SE revenue growthUnited Therapeutics revenue growthBioNTech SE free cash flowUnited Therapeutics free cash flow
BioNTech SE & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.